CoChat

Immunobiology of primary sclerosing cholangitis

Open access

The DOI matches its Crossref record; 165 of the 165 references it cites were found in a registry or an index.

Abstract

Primary sclerosing cholangitis (PSC) is a chronic inflammatory progressive cholestatic liver disease. Genetic risk factors, the presence of autoantibodies, the strong clinical link with inflammatory bowel disease, and associations with other autoimmune disorders all suggest a pivotal role for the immune system in PSC pathogenesis. In this review, we provide a comprehensive overview of recent immunobiology insights in PSC. A particular emphasis is given to immunological concepts such as tissue residency and knowledge gained from novel technologies, including single-cell RNA sequencing and spatial transcriptomics. This review of the immunobiological landscape of PSC covers major immune cell types known to be enriched in PSC-diseased livers as well as recently described cell types whose biliary localization and contribution to PSC immunopathogenesis remain incompletely described. Finally, we emphasize the importance of time and space in relation to PSC heterogeneity as a key consideration for future studies interrogating the role of the immune system in PSC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/hep.0000000000001080

Cites

165 of 165 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIGURE 1 Overview of PSC immunobiology. Summary of the immune features from PSC livers is presented in extended circles depending on the techniques used. These mainly arise from studies on parenchyma of advanced PSC livers, whereas less is known regarding extrahepatic bile duct, intrahepatic and extrahepatic strictures, gallbladder, or intrahepatic small duct areas as indicated by the areas of interest box. Immune cells and specific features/findings are depicted by colored circles, symbols, and letters. Analysis of cell suspensions shows the immune composition of the biliary tree (cytobrushing) and the global modifications of the immune system in the liver parenchyma. Spatial analysis highlights differences within the liver based on a central to portal (PV) axis, bile-duct interacting (BD) cells, as well as in fibrotic versus nonfibrotic areas. Abbreviations: BD, bile duct; PSC, primary sclerosing cholangitis; PV, portal vein.
FIGURE 1 Overview of PSC immunobiology. Summary of the immune features from PSC livers is presented in extended circles depending on the techniques used. These mainly arise from studies on parenchyma of advanced PSC livers, whereas less is known regarding extrahepatic bile duct, intrahepatic and extrahepatic strictures, gallbladder, or intrahepatic small duct areas as indicated by the areas of interest box. Immune cells and specific features/findings are depicted by colored circles, symbols, and letters. Analysis of cell suspensions shows the immune composition of the biliary tree (cytobrushing) and the global modifications of the immune system in the liver parenchyma. Spatial analysis highlights differences within the liver based on a central to portal (PV) axis, bile-duct interacting (BD) cells, as well as in fibrotic versus nonfibrotic areas. Abbreviations: BD, bile duct; PSC, primary sclerosing cholangitis; PV, portal vein.CC BY · PubMed Central
FIGURE 2 PSC pathogenesis through time, space, comorbidities, and clinical heterogeneity. Locations (space) of the immune studies are indicated in the left part of the figure. The extent of immunological knowledge in relation to disease stage (time) is thereafter depicted (preclinical, postdiagnosis/advanced disease, and posttransplant recurrent PSC). Most of the current immunobiological knowledge originates from a narrow spatiotemporal window, mostly from liver tissue postdiagnosis or in end-stage disease. The main immune features per location are detailed in bullet points. On the right side, related comorbidities and clinical heterogeneity–related aspects for each location are brought up. In most instances, it remains unclear how these aspects affect immunology. Abbreviation: PSC, primary sclerosing cholangitis.
FIGURE 2 PSC pathogenesis through time, space, comorbidities, and clinical heterogeneity. Locations (space) of the immune studies are indicated in the left part of the figure. The extent of immunological knowledge in relation to disease stage (time) is thereafter depicted (preclinical, postdiagnosis/advanced disease, and posttransplant recurrent PSC). Most of the current immunobiological knowledge originates from a narrow spatiotemporal window, mostly from liver tissue postdiagnosis or in end-stage disease. The main immune features per location are detailed in bullet points. On the right side, related comorbidities and clinical heterogeneity–related aspects for each location are brought up. In most instances, it remains unclear how these aspects affect immunology. Abbreviation: PSC, primary sclerosing cholangitis.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 165 references

Cited by

See all 20

Metadata

Authors
Cornillet, M., Geanon, D., Bergquist, A., & Björkström, N. K.
Affiliations
Karolinska University Hospital (SE)
Corresponding author
Björkström, Niklas K.
Venue
Hepatology
Published
2024-09-02
Volume
82
Issue
4
Pages
911-926
ISSN
  • 0270-9139 (ISSN-L)
  • 1527-3350
OpenAlex
W4402215835
Cited by
20
References
161
Citations by year
2026: 11 · 2025: 9
FWCI
1.44
Type
journal article
Language
en
Open access
Locations
  • Hepatology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • European Commission (HORIZON2020)
  • Cancerfonden
  • Karolinska Institutet
  • Vetenskapsrådet
  • Novo Nordisk Fonden (NNF21OC0067824)
  • Center for Innovative Medicine
Topics
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
  • Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
  • Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
Keywords
primary sclerosing cholangitis, immunopathogenesis, immune cell composition, single-cell RNA sequencing, spatial transcriptomics, autoantibodies, inflammatory bowel disease, autoimmune disease, cholestatic liver disease
MeSH terms
Humans, Cholangitis, Sclerosing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Immunobiology of primary sclerosing cholangitis. https://app.cochat.ai/papers/10.1097/hep.0000000000001080
The paper
Cornillet, M., Geanon, D., Bergquist, A., & Björkström, N. K. (2025). Immunobiology of primary sclerosing cholangitis. Hepatology. https://doi.org/10.1097/hep.0000000000001080

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.